Altogether, a large body of evidence demonstrates that the NLRP3 inflammasome contributes significantly to the development and progression of obesity-associated comorbidities such as IR, T2DM, atherosclerosis and NAFLD. This evidence concerns the gene NLRP3 and type 2 diabetes mellitus.